News

Moderna on Thursday pushed back the time frame for likely approval of a combination vaccine meant to protect against both ...
The FDA plans to limit access to certain high-risk groups and also told Pfizer and Moderna to update their warning labels ...
Moderna isn’t giving up on the combo shot entirely—it plans to resubmit later this year after it collects more data from its ...
Infectious disease experts say mRNA vaccines have been studied for decades, they are safe and effective, and were instrumental in saving lives during the COVID pandemic.
In terms of liquidity and interest, the mean open interest for Moderna options trades today is 1389.55 with a total volume of ...
Moderna Inc. said it has “voluntarily” withdrawn its application for regulatory approval for its combination Covid and flu ...
The Trump administration shared the outlines of how it plans to push drug companies to lower their prices in the U.S.